Autolus Therapeutics
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
AngelList URL
B2X
Board of Directors
CEO
CIK Number
Legal Name
Autolus Therapeutics plc
Company Operating Status
Active
Contact Page URL
Country
Crunchbase URL
Date Incorporated
February 2, 2018
Email Address
contact@autolus.com
0
j.wilson@autolus.com
0
linicaltrials@autolus.com
0
Founded Date
2014
Founder
Full Address
191 Wood Lane White City London W12 7FP
0
Headquarters
Incorporation Reference
09115837
Latest Funding Round Date
February 2021
Latest Funding Round Amount (USD)
100,000,000
Latest Funding Type
Legal Entity Identifier
Legal classification
LinkedIn URL
Number of Employees (Ranges)
51 – 200
Parent Organization
Phone Number
+441483920748
0
+442038296230
0
+447818430877
0
Place of Incorporation
Previous Name
Autolus Therapeutics Ltd
0
SIC Code
2,836
0
Spun Out From
Exchange
Stock Symbol
AUTL
0
Total Funding Amount (USD)
457,114,430
UKSIC Code
74909
Official Website
Wellfound ID
Wikidata ID
Find more companies like Autolus Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.